RNA, U6atac small nuclear 22, pseudogene (RNU6ATAC22P)

RNU6ATAC22P is classified as a **pseudogene** of a **small nuclear RNA (snRNA)** from the U6atac family, specifically the 22nd paralog in this series[3]. Pseudogenes are genomic sequences similar to functional genes but are typically non-coding due to mutations or truncations. While historically considered non-functional, some pseudogenes can have roles in gene regulation—such as acting as competitive endogenous RNAs (ceRNAs), producing small interfering RNAs, or serving as microRNA sponges[1][5]. However, there is no evidence that RNU6ATAC22P itself encodes a protein or acts as a direct therapeutic target. Its main relevance is as an **RNA, U6atac small nuclear pseudogene**, potentially reflecting the evolutionary dynamics of small RNA retrotransposition in the genome[3][4]. There are currently no described drugs, mechanisms of action, or biomarker uses associated with RNU6ATAC22P, nor is it regarded as a disease gene, though general research on pseudogenes suggests they may indirectly influence disease processes in specific contexts[1][5].

Other names

RNU6ATAC22P